White Matter Damage in Asymptomatic Patients with Sickle Cell Anemia: Screening with Diffusion Tensor Imaging

References

1. 1.↵
   1. Ohene-Frempong K,
   2. Weiner SJ,
   3. Sleeper LA,
   4. et al

   . Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998; 91: 288–94

   Abstract/FREE Full Text
2. 2.↵
   1. Pegelow CH,
   2. Macklin EA,
   3. Moser FG,
   4. et al

   . Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 2002; 99: 3014–18

   Abstract/FREE Full Text
3. 3.↵
   1. Cohen MJ,
   2. Branch WB,
   3. McKie VC,
   4. et al

   . Neuropsychological impairment in children with sickle cell anemia and cerebrovascular accidents. Clin Pediatr (Phila) 1994; 33: 517–24

   Abstract/FREE Full Text
4. 4.↵
   1. Watkins KE,
   2. Hewes DK,
   3. Connelly A,
   4. et al

   . Cognitive deficits associated with frontal-lobe infarction in children with sickle cell disease. Dev Med Child Neurol 1998; 40: 536–43

   PubMedWeb of Science
5. 5.↵
   1. Wilimas J,
   2. Goff JR,
   3. Anderson HR Jr.,
   4. et al

   . Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. J Pediatr 1980; 96: 205–08

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Bernaudin F,
   2. Verlhac S,
   3. Freard F,
   4. et al

   . Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. J Child Neurol 2000; 15: 333–43

   Abstract/FREE Full Text
7. 7.↵
   1. Schatz J,
   2. Finke R,
   3. Roberts CW

   . Interactions of biomedical and environmental risk factors for cognitive development: a preliminary study of sickle cell disease. J Dev Behav Pediatr 2004; 25: 303–10

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Wang W,
   2. Enos L,
   3. Gallagher D,
   4. et al

   . Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr 2001; 139: 391–97

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Hijmans CT,
   2. Grootenhuis MA,
   3. Oosterlaan J,
   4. et al

   . Neurocognitive deficits in children with sickle cell disease are associated with the severity of anemia. Pediatr Blood Cancer 2011; 57: 297–302

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Steen RG,
    2. Emudianughe T,
    3. Hunte M,
    4. et al

    . Brain volume in pediatric patients with sickle cell disease: evidence of volumetric growth delay? AJNR Am J Neuroradiol 2005; 26: 455–62

    Abstract/FREE Full Text
11. 11.↵
    1. Steen RG,
    2. Langston JW,
    3. Ogg RJ,
    4. et al

    . Diffuse T1 reduction in gray matter of sickle cell disease patients: evidence of selective vulnerability to damage? Magn Reson Imaging 1999; 17: 503–15

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Vichinsky EP,
    2. Neumayr LD,
    3. Gold JI,
    4. et al

    . Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA 2010; 303: 1823–31

    CrossRefPubMed
13. 13.↵
    1. Berkelhammer LD,
    2. Williamson AL,
    3. Sanford SD,
    4. et al

    . Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature. Child Neuropsychol 2007; 13: 120–31

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Wang WC

    . Sickle-cell disease and compromised cognition. Pediatr Blood Cancer 2011; 56: 705–06

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Kirk GR,
    2. Haynes MR,
    3. Palasis S,
    4. et al

    . Regionally specific cortical thinning in children with sickle cell disease. Cereb Cortex 2009; 19: 1549–56

    Abstract/FREE Full Text
16. 16.↵
    1. Baldeweg T,
    2. Hogan AM,
    3. Saunders DE,
    4. et al

    . Detecting white matter injury in sickle cell disease using voxel-based morphometry. Ann Neurol 2006; 59: 662–72

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Scantlebury N,
    2. Mabbott D,
    3. Janzen L,
    4. et al

    . White matter integrity and core cognitive function in children diagnosed with sickle cell disease. J Pediatr Hematol Oncol 2011; 33: 163–71

    CrossRefPubMed
18. 18.↵
    1. Bookstein FL

    . “Voxel-based morphometry” should not be used with imperfectly registered images. Neuroimage 2001; 14: 1454–62

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Smith SM,
    2. Jenkinson M,
    3. Johansen-Berg H,
    4. et al

    . Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006; 31: 1487–505

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Xu D,
    2. Cui J,
    3. Bansal R,
    4. et al

    . The ellipsoidal area ratio: an alternative anisotropy index for diffusion tensor imaging. Magn Reson Imaging 2009; 27: 311–23

    CrossRefPubMed
21. 21.↵
    1. Smith SM,
    2. Nichols TE

    . Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 2009; 44: 83–98

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Woodard P,
    2. Helton KJ,
    3. Khan RB,
    4. et al

    . Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease. Br J Haematol 2005; 129: 550–52

    CrossRefPubMed
23. 23.↵
    1. Song SK,
    2. Sun SW,
    3. Ramsbottom MJ,
    4. et al

    . Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002; 17: 1429–36

    CrossRefPubMedWeb of Science
24. 24.↵
    1. DeBoy CA,
    2. Zhang J,
    3. Dike S,
    4. et al

    . High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord. Brain 2007; 130: 2199–210

    Abstract/FREE Full Text
25. 25.↵
    1. Wheeler-Kingshott CA,
    2. Cercignani M

    . About “axial” and “radial” diffusivities. Magn Reson Med 2009; 61: 1255–60

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Asato MR,
    2. Terwilliger R,
    3. Woo J,
    4. et al

    . White matter development in adolescence: a DTI study. Cereb Cortex 2010; 20: 2122–31

    Abstract/FREE Full Text
27. 27.↵
    1. Schatz J,
    2. Buzan R

    . Decreased corpus callosum size in sickle cell disease: relationship with cerebral infarcts and cognitive functioning. J Int Neuropsychol Soc 2006; 12: 24–33

    PubMed